Charles Schwab Investment Management »

Actuate Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $99k 15k 6.69
2025-06-30 $90k 15k 6.11